Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis Dee LinPhilippe Thompson-LeducPatrick Lefebvre Systematic Review Open access 28 April 2021 Pages: 469 - 481
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis Colin J. MahoneyRebekah M. AhmedMatthew C. Kiernan Review Article 15 May 2021 Pages: 483 - 505
Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review Frank M. C. BesagMichael J. VaseyIffah Salim Review Article 20 April 2021 Pages: 507 - 526
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status Ioline D. HenterLawrence T. ParkCarlos A. Zarate Jr. Review Article 26 April 2021 Pages: 527 - 543
The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update Christina Sun-EdelsteinAlan M. RapoportAnan Srikiatkhachorn Review Article 17 May 2021 Pages: 545 - 565
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate) Thomas W. LateganLaurene WangFranck S. Rousseau Original Research Article Open access 30 March 2021 Pages: 567 - 574
Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA Sepehr FarahbakhshianRajeev AyyagariWilliam Spalding Original Research Article Open access 15 April 2021 Pages: 575 - 589